Recent clinical trials of immunotherapy in non-small-cell lung cancer

被引：7
|
作者：
Gkolfinopoulos, Stavros [1 ]
Mountzios, Giannis [2 ]
机构：
[1] BOC Oncol Ctr, Med Oncol Dept, CY-2006 Nicosia, Cyprus
[2] Henry Dunant Hosp Ctr, Med Oncol Dept 2, Athens 11526, Greece
来源：
IMMUNOTHERAPY | 2019年 / 11卷 / 06期
关键词：
atezolizumab; avelumab; checkpoint inhibitors; durvalumab; ipilimumab; nivolumab; non-small-cell lung cancer; pembrolizumab; DOCETAXEL; NIVOLUMAB; INTERLEUKIN-2; ATEZOLIZUMAB; BURDEN;
D O I：
10.2217/imt-2019-0021
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：461 / 466
页数：6
相关论文
共 50 条
  • [41] Postoperative adjuvant chemotherapy in non-small-cell lung cancer - review of clinical trials with randomization
    Ploch-Glapinska, Malgorzata
    Zapedowska, Jolanta
    Krzakowski, Maciej
    ONCOLOGY IN CLINICAL PRACTICE, 2005, 1 (02): : 63 - 71
  • [42] Assessment of quality of life in advanced non-small-cell lung cancer: An overview of recent randomized trials
    Saad, Everardo D.
    Adamowicz, Krzysztof
    Katz, Artur
    Jassem, Jacek
    CANCER TREATMENT REVIEWS, 2012, 38 (06) : 807 - 814
  • [43] The future of cancer vaccines for non-small-cell lung cancer: Ongoing trials
    Choudhury, Aniruddha
    Palma, Marzia
    Mellstedt, Hakan
    CLINICAL LUNG CANCER, 2008, 9 : S37 - S44
  • [44] The eligibility of advanced non-small-cell lung cancer patients for targeted therapy clinical trials
    Clarey, J.
    Kao, S. C.
    Clarke, S. J.
    Vardy, J.
    ANNALS OF ONCOLOGY, 2012, 23 (05) : 1229 - 1233
  • [45] Quality trials and quality of life in non-small-cell lung cancer
    Harper, P
    Plunkett, T
    Khayat, D
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (16) : 3007 - 3008
  • [46] Analysis of time-to-treatment discontinuation of targeted therapy, immunotherapy, and chemotherapy in clinical trials of patients with non-small-cell lung cancer
    Blumenthal, G. M.
    Gong, Y.
    Kehl, K.
    Mishra-Kalyani, P.
    Goldberg, K. B.
    Khozin, S.
    Kluetz, P. G.
    Oxnard, G. R.
    Pazdur, R.
    ANNALS OF ONCOLOGY, 2019, 30 (05) : 830 - 838
  • [47] ICTIS: A Novel Scoring System to Assess the Inclusivity of Metastatic Non-Small-Cell Lung Cancer Immunotherapy Trials
    Nguyen, K.
    Wei, A.
    Aung, W. Y.
    Spinelli, N.
    Seetharamu, N.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S612 - S612
  • [48] Italian clinical research in non-small-cell lung cancer
    Gridelli, Cesare
    Rossi, A.
    Galetta, D.
    Maione, P.
    Ferrara, C.
    Guerriero, C.
    Del Gaizo, F.
    Nicolella, D.
    Colantuoni, G.
    Gebbia, V.
    Colucci, G.
    ANNALS OF ONCOLOGY, 2005, 16 : 110 - 115
  • [49] New clinical strategies in non-small-cell lung cancer
    Greco, FA
    ONCOLOGY-NEW YORK, 1999, 13 (09): : 60 - 64
  • [50] Clinical experience with erlotinib in non-small-cell lung cancer
    Felip, Enriqueta
    Rosell, Rafael
    DRUGS OF TODAY, 2006, 42 (03) : 147 - 156
12345